Juan Francisco Llamazares and Federico D'alvia

The first biotech production global network

Leveraging state-of-the-art technologies such as microfluidics, electroporation and robotics, Stämm is bringing the 4.0. revolution to biotech. Stämm seeks to multiply the efficiency, flexibility and decentralization of the manufacturing of biotechnological products for the pharmaceutical and food industry. It’s looking to implement the first global biotech production network and sell its production capacity as a service to the industry.